Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00893 |
| Species: | Homo sapiens |
| Position : | chr2:16619625-16621501 |
| Year: | 2023 |
| Title: | TAL1 hijacks MYCN enhancer that induces MYCN expression and dependence on mevalonate pathway in T-cell acute lymphoblastic leukemia. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | T-cell acute lymphoblastic leukemia |
| PMID: | 37591943 |
| MONDO: | MONDO:0004963 |
| Tissue: | blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | Jurkat |
| CVCL ID: | CVCL_0065 |
| Cell Type: | T lymphoblast |
| Cell Ontology ID: | CL:0000084 |
| Experiment Type: | Enhancer activity assay, TF binding assay, Chromatin interaction assay, Functional perturbation assay |
| High Throughput Method: | ChIP-seq; ATAC-seq; Hi-C, 4C-seq |
| Low Throughput Method: | Luciferase Reporter Assay; CRISPR Knockout; CRISPRi; ChIP-RT-qPCR; RT-RT-qPCR; Western blot |
| Target gene : | MYCN |
| TF name : | TAL1 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|